Senior insider sale
PRESIDENT AND CEO at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$148.3K
40.80K shares
What this filing means
AUERBACH ALAN H plans to sell 40.80K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $148.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/17/2024ACC: 0001610717-24-000399
DirectorOfficer10% Owner· PRESIDENT AND CEO
Since Jul 2018
40.80K
Shares to sell
$148.3K
Approx. market value
160.80K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Compensation for Services Rendered
2/12/2024
160.80KTotal acquired160.80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/12/2024 | Restricted Stock Unit Grant Compensation for Services Rendered | 160.80K | — |
| Total | 160.80K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
18.89K
Market value
$61.7K
7/2/2024
Planned — Approximate Date
NASDAQGSPlanned
Units to sell
21.92K
Market value
$86.6K
7/17/2024
Total
Units
40.80K
Value
$148.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/2/2024 | 18.89K | $61.7K | — | Completed |
| Planned — Approximate Date | ||||
7/17/2024 | 21.92K | $86.6K | NASDAQGS | Planned |
| Total | 40.80K | $148.3K | ||